$MRK Headlines
Planned layoffs up 13.5% in October: Challenger 7:30 a.m. Today - Steve Goldstein
Newscast: S&P 500 notches year's 32nd record high 8:08 p.m. Oct. 28, 2013 - MarketWatch
J.C. Penney, Bristol-Myers top S&P 500 7:08 p.m. Oct. 28, 2013 - Saumya Vaishampayan
S&P up for 8th day in 9; Dow, Nasdaq flat 4:57 p.m. Oct. 28, 2013 - Victor Reklaitis
Newscast: Stocks mixed after lackluster day 4:26 p.m. Oct. 28, 2013 - MarketWatch
Newscast: Car reliability ranks get new members 2:28 p.m. Oct. 28, 2013 - MarketWatch
Merck shares stumble on earnings weakness, talk of divesting assets 10:58 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Merck, down 2.2%, leads Dow average lower 9:34 a.m. Oct. 28, 2013 - Laura Mandaro
Stock futures continue to waver after data 9:30 a.m. Oct. 28, 2013 - Sara Sjolin
Apple is Monday’s stock to watch as results loom 8:21 a.m. Oct. 28, 2013 - Sue Chang
Merck profit down 35% as Singulair sales fall 7:25 a.m. Oct. 28, 2013 - MarketWatch.com
Merck third-quarter profit, revenue fall 7:17 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck narrows 2013 EPS guidance; holds sales view 7:10 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 adj. EPS edges down to $0.92 vs. $0.95 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 sales down to $11.03 bln vs. $11.49 bln 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 profit falls to $1.12 bln vs. $1.73 bln 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 EPS falls to $0.38 from $0.56 year ago 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Small caps surge, the year's best trading day and R.I.P. Lou Reed 6:37 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Earnings season focus shifts to revenue, capex 9:52 a.m. Oct. 27, 2013 - Wallace Witkowski
The next big pharma 7:01 a.m. Oct. 25, 2013 - The Trading Deck
Boeing Will Make Key 777X Parts in Seattle and 2 Other Dow Movers to Watch 1:14 p.m. Today - Wall St. Cheat Sheet
Earnings Beat at Hospira in Q3, View maintained - Analyst Blog 12:27 p.m. Today - Zacks.com
Narrower-than-Expected Loss at Endocyte - Analyst Blog 10:50 a.m. Today - Zacks.com
Merck & Co Inc's Buy Recommendation Affirmed 9:00 a.m. Today - TheStreet.com
Will GlaxoSmithKline Continue to Trend Higher? 8:29 a.m. Today - Wall St. Cheat Sheet
Bristol-Myers Not Done Climbing 6:30 a.m. Today - TheStreet.com
Cramer's Lightning Round - Alcoa Is Creeping Up (11/5/13) 6:09 a.m. Today - Seeking Alpha
'Mad Money' Lightning Round: ConocoPhillips Is Terrific 5:45 a.m. Today - TheStreet.com
7 Generous Dividend Stocks Giving Big Cash Back to Shareholders 1:00 a.m. Today - InvestorPlace.com
Jim Cramer's 'Mad Money' Recap: Got Growth? 8:27 p.m. Nov. 5, 2013 - TheStreet.com
3M Finalizes Asian Investments to Support Window Film and 2 Other Dow Movers to Watch 4:56 p.m. Nov. 5, 2013 - Wall St. Cheat Sheet
Ligand Pharmaceuticals On Pace For Annual Profit 4:25 p.m. Nov. 5, 2013 - Investors Business Daily
Here’s How Pharma Stocks Are Outperforming the S&P 500 1:31 p.m. Nov. 5, 2013 - Wall St. Cheat Sheet
Insider Trading Alert - OPK, ALGN, AREX, IBKR And MRK Traded By Insiders 2:10 p.m. Nov. 4, 2013 - TheStreet.com
DoJ Wants Divestments from US Airways, Amazon Preps ‘Alpha House,’ and 3 More Hot Stocks 12:58 p.m. Nov. 4, 2013 - Wall St. Cheat Sheet
Dow Today: Merck (MRK) Leads The Day Higher, E.I. Du Pont De Nemours & Company (DD) Lags 10:00 a.m. Nov. 4, 2013 - TheStreet.com
Analysts Comment on Merck's Hep C Regiment Advances 9:39 a.m. Nov. 4, 2013 - benzinga.com
Merck (MRK) Strong In Pre-Market Trading 8:38 a.m. Nov. 4, 2013 - TheStreet.com
Pfizer's Not Losing Its Kingpin Status 6:00 a.m. Nov. 4, 2013 - TheStreet.com
Merck: Why Oncology Smells Like Money 5:39 a.m. Nov. 4, 2013 - Seeking Alpha
Positive Clinical Data, Upcoming Presentations, and Completed Acquisitions - Research Report on Merck, Perrigo, Celgene, Cigna, and Boston Scientific 8:00 a.m. Today - PR Newswire
Merck Animal Health Launches Global Awareness Campaign to Support Pet Diabetes Month(TM) 6:42 p.m. Nov. 5, 2013 - PR Newswire
Regado Biosciences, Inc. Appoints World-Renowned Leader in Cardiovascular Research and Former Global Head of Cardiovascular Diseases for Merck & Co., to Board of Directors 5:01 p.m. Nov. 5, 2013 - PR Newswire
InSite Vision Announces Appeal by Sandoz Inc. of Court Judgment Upholding All AzaSite(R) Patents in Patent Infringement Lawsuit 4:36 p.m. Nov. 5, 2013 - BusinessWire
Codexis Appoints Greg Hughes, Ph.D., as Vice President, Strategic Alliance & Product Development 4:01 p.m. Nov. 5, 2013 - BusinessWire
Surprising Earnings and News Updates: General Motors, BlackBerry, American International Group, First Solar, Merck & Co. 1:55 p.m. Nov. 4, 2013 - PR Newswire
Fitch: Pharmaceutical Cost Cutting Still Includes R&D for Some 11:18 a.m. Nov. 4, 2013 - BusinessWire
Presentation, Quarterly Reports, and FDA Approval - Research Report on Merck, United Therapeutics, Endo, Isis Pharmaceuticals, and Zogenix 8:00 a.m. Nov. 4, 2013 - PR Newswire
Merck's Investigational 9-valent HPV Vaccine, V503, Prevented 97 Percent of Cervical, Vaginal and Vulvar Pre-cancers Caused by Five Additional HPV Types, in Phase III Study 7:30 a.m. Nov. 4, 2013 - BusinessWire
Merck Announces Presentation of Interim Data from Study of Investigational Combination of HCV Therapies MK-5172 and MK-8742 at the 2013 American Association for the Study of Liver Diseases (AASLD) Annual Meeting 9:00 a.m. Nov. 2, 2013 - BusinessWire
Clinical Studies, Regulatory Clearance, Financial Results, and Approvals - Research Report on Bristol-Myers Squibb, Merck & Co., Johnson & Johnson, AbbVie, and Novartis 9:00 a.m. Oct. 31, 2013 - PR Newswire
Merck Announces Presentation of Interim Data from Phase 1B Study of MK-3475, Investigational anti-PD-1 Immunotherapy, in Previously-Treated Patients with Non-Small Cell Lung Cancer (NSCLC) at 15th World Conference on Lung Cancer 1:15 a.m. Oct. 29, 2013 - BusinessWire
NQ, FIO, MRK and PBR added to NYSE Active Stock Watch List at GSR 10:55 a.m. Oct. 28, 2013 - ACCESSWIRE
EMD Serono and Open Monoclonal Technology Expand Collaboration to Include Unlimited Access to OmniRat(R) Human Antibody Platform 8:00 a.m. Oct. 28, 2013 - BusinessWire
Merck Announces Third-Quarter 2013 Financial Results 7:00 a.m. Oct. 28, 2013 - BusinessWire
ABLYNX TO PRESENT PRE-CLINICAL PROOF-OF-CONCEPT DATA ON ALX-0761 AT ACR 2:49 a.m. Oct. 28, 2013 - GlobeNewswire
ABLYNX TO PRESENT PRE-CLINICAL PROOF-OF-CONCEPT DATA ON ALX-0761 AT ACR 2:30 a.m. Oct. 28, 2013 - Thomson Reuters ONE
Pre-Market Analysis: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. 10:12 a.m. Oct. 25, 2013 - PR Newswire
Merck Provides Update on Investigational 9-valent HPV Vaccine V503 to U.S. Advisory Committee on Immunization Practices 10:27 a.m. Oct. 24, 2013 - BusinessWire
ZOSTAVAX(R) (Zoster Vaccine Live) Awarded Prix Galien USA 2013 Best Biotechnology Product 7:30 a.m. Oct. 23, 2013 - BusinessWire
Planned layoffs up 13.5% in October: Challenger 7:30 a.m. Today - Steve Goldstein
Newscast: S&P 500 notches year's 32nd record high 8:08 p.m. Oct. 28, 2013 - MarketWatch
J.C. Penney, Bristol-Myers top S&P 500 7:08 p.m. Oct. 28, 2013 - Saumya Vaishampayan
S&P up for 8th day in 9; Dow, Nasdaq flat 4:57 p.m. Oct. 28, 2013 - Victor Reklaitis
Newscast: Stocks mixed after lackluster day 4:26 p.m. Oct. 28, 2013 - MarketWatch
Newscast: Car reliability ranks get new members 2:28 p.m. Oct. 28, 2013 - MarketWatch
Merck shares stumble on earnings weakness, talk of divesting assets 10:58 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Merck, down 2.2%, leads Dow average lower 9:34 a.m. Oct. 28, 2013 - Laura Mandaro
Stock futures continue to waver after data 9:30 a.m. Oct. 28, 2013 - Sara Sjolin
Apple is Monday’s stock to watch as results loom 8:21 a.m. Oct. 28, 2013 - Sue Chang
Merck profit down 35% as Singulair sales fall 7:25 a.m. Oct. 28, 2013 - MarketWatch.com
Merck third-quarter profit, revenue fall 7:17 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck narrows 2013 EPS guidance; holds sales view 7:10 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 adj. EPS edges down to $0.92 vs. $0.95 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 sales down to $11.03 bln vs. $11.49 bln 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 profit falls to $1.12 bln vs. $1.73 bln 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 EPS falls to $0.38 from $0.56 year ago 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Small caps surge, the year's best trading day and R.I.P. Lou Reed 6:37 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Earnings season focus shifts to revenue, capex 9:52 a.m. Oct. 27, 2013 - Wallace Witkowski
The next big pharma 7:01 a.m. Oct. 25, 2013 - The Trading Deck
Boeing Will Make Key 777X Parts in Seattle and 2 Other Dow Movers to Watch 1:14 p.m. Today - Wall St. Cheat Sheet
Earnings Beat at Hospira in Q3, View maintained - Analyst Blog 12:27 p.m. Today - Zacks.com
Narrower-than-Expected Loss at Endocyte - Analyst Blog 10:50 a.m. Today - Zacks.com
Merck & Co Inc's Buy Recommendation Affirmed 9:00 a.m. Today - TheStreet.com
Will GlaxoSmithKline Continue to Trend Higher? 8:29 a.m. Today - Wall St. Cheat Sheet
Bristol-Myers Not Done Climbing 6:30 a.m. Today - TheStreet.com
Cramer's Lightning Round - Alcoa Is Creeping Up (11/5/13) 6:09 a.m. Today - Seeking Alpha
'Mad Money' Lightning Round: ConocoPhillips Is Terrific 5:45 a.m. Today - TheStreet.com
7 Generous Dividend Stocks Giving Big Cash Back to Shareholders 1:00 a.m. Today - InvestorPlace.com
Jim Cramer's 'Mad Money' Recap: Got Growth? 8:27 p.m. Nov. 5, 2013 - TheStreet.com
3M Finalizes Asian Investments to Support Window Film and 2 Other Dow Movers to Watch 4:56 p.m. Nov. 5, 2013 - Wall St. Cheat Sheet
Ligand Pharmaceuticals On Pace For Annual Profit 4:25 p.m. Nov. 5, 2013 - Investors Business Daily
Here’s How Pharma Stocks Are Outperforming the S&P 500 1:31 p.m. Nov. 5, 2013 - Wall St. Cheat Sheet
Insider Trading Alert - OPK, ALGN, AREX, IBKR And MRK Traded By Insiders 2:10 p.m. Nov. 4, 2013 - TheStreet.com
DoJ Wants Divestments from US Airways, Amazon Preps ‘Alpha House,’ and 3 More Hot Stocks 12:58 p.m. Nov. 4, 2013 - Wall St. Cheat Sheet
Dow Today: Merck (MRK) Leads The Day Higher, E.I. Du Pont De Nemours & Company (DD) Lags 10:00 a.m. Nov. 4, 2013 - TheStreet.com
Analysts Comment on Merck's Hep C Regiment Advances 9:39 a.m. Nov. 4, 2013 - benzinga.com
Merck (MRK) Strong In Pre-Market Trading 8:38 a.m. Nov. 4, 2013 - TheStreet.com
Pfizer's Not Losing Its Kingpin Status 6:00 a.m. Nov. 4, 2013 - TheStreet.com
Merck: Why Oncology Smells Like Money 5:39 a.m. Nov. 4, 2013 - Seeking Alpha
Positive Clinical Data, Upcoming Presentations, and Completed Acquisitions - Research Report on Merck, Perrigo, Celgene, Cigna, and Boston Scientific 8:00 a.m. Today - PR Newswire
Merck Animal Health Launches Global Awareness Campaign to Support Pet Diabetes Month(TM) 6:42 p.m. Nov. 5, 2013 - PR Newswire
Regado Biosciences, Inc. Appoints World-Renowned Leader in Cardiovascular Research and Former Global Head of Cardiovascular Diseases for Merck & Co., to Board of Directors 5:01 p.m. Nov. 5, 2013 - PR Newswire
InSite Vision Announces Appeal by Sandoz Inc. of Court Judgment Upholding All AzaSite(R) Patents in Patent Infringement Lawsuit 4:36 p.m. Nov. 5, 2013 - BusinessWire
Codexis Appoints Greg Hughes, Ph.D., as Vice President, Strategic Alliance & Product Development 4:01 p.m. Nov. 5, 2013 - BusinessWire
Surprising Earnings and News Updates: General Motors, BlackBerry, American International Group, First Solar, Merck & Co. 1:55 p.m. Nov. 4, 2013 - PR Newswire
Fitch: Pharmaceutical Cost Cutting Still Includes R&D for Some 11:18 a.m. Nov. 4, 2013 - BusinessWire
Presentation, Quarterly Reports, and FDA Approval - Research Report on Merck, United Therapeutics, Endo, Isis Pharmaceuticals, and Zogenix 8:00 a.m. Nov. 4, 2013 - PR Newswire
Merck's Investigational 9-valent HPV Vaccine, V503, Prevented 97 Percent of Cervical, Vaginal and Vulvar Pre-cancers Caused by Five Additional HPV Types, in Phase III Study 7:30 a.m. Nov. 4, 2013 - BusinessWire
Merck Announces Presentation of Interim Data from Study of Investigational Combination of HCV Therapies MK-5172 and MK-8742 at the 2013 American Association for the Study of Liver Diseases (AASLD) Annual Meeting 9:00 a.m. Nov. 2, 2013 - BusinessWire
Clinical Studies, Regulatory Clearance, Financial Results, and Approvals - Research Report on Bristol-Myers Squibb, Merck & Co., Johnson & Johnson, AbbVie, and Novartis 9:00 a.m. Oct. 31, 2013 - PR Newswire
Merck Announces Presentation of Interim Data from Phase 1B Study of MK-3475, Investigational anti-PD-1 Immunotherapy, in Previously-Treated Patients with Non-Small Cell Lung Cancer (NSCLC) at 15th World Conference on Lung Cancer 1:15 a.m. Oct. 29, 2013 - BusinessWire
NQ, FIO, MRK and PBR added to NYSE Active Stock Watch List at GSR 10:55 a.m. Oct. 28, 2013 - ACCESSWIRE
EMD Serono and Open Monoclonal Technology Expand Collaboration to Include Unlimited Access to OmniRat(R) Human Antibody Platform 8:00 a.m. Oct. 28, 2013 - BusinessWire
Merck Announces Third-Quarter 2013 Financial Results 7:00 a.m. Oct. 28, 2013 - BusinessWire
ABLYNX TO PRESENT PRE-CLINICAL PROOF-OF-CONCEPT DATA ON ALX-0761 AT ACR 2:49 a.m. Oct. 28, 2013 - GlobeNewswire
ABLYNX TO PRESENT PRE-CLINICAL PROOF-OF-CONCEPT DATA ON ALX-0761 AT ACR 2:30 a.m. Oct. 28, 2013 - Thomson Reuters ONE
Pre-Market Analysis: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. 10:12 a.m. Oct. 25, 2013 - PR Newswire
Merck Provides Update on Investigational 9-valent HPV Vaccine V503 to U.S. Advisory Committee on Immunization Practices 10:27 a.m. Oct. 24, 2013 - BusinessWire
ZOSTAVAX(R) (Zoster Vaccine Live) Awarded Prix Galien USA 2013 Best Biotechnology Product 7:30 a.m. Oct. 23, 2013 - BusinessWire
